Epitalon 50 mg

Dragon Pharma Epitalon

Epitalon 50 mg provides a concentrated research dose of the synthetic tetrapeptide (Ala-Glu-Asp-Gly) that mirrors the biologically active site of the natural pineal gland peptide Epithalamin. Originally developed by Russian professor Vladimir Khavinson, Epitalon represents a breakthrough in gerontological research for its potential to influence fundamental aging processes at the cellular level. Its primary mechanisms of action involve the upregulation of telomerase activity—the enzyme responsible for maintaining telomere length at chromosome ends—and the normalization of pineal gland function, which regulates circadian rhythms and melatonin production. By supporting these core biological systems, Epitalon has become a premier subject in anti-aging, longevity, and cellular health research.

For bodybuilders, athletes, and longevity researchers in the USA, Dragon Pharma Epitalon 50 mg offers a unique research tool that operates at the intersection of performance enhancement and cellular rejuvenation. Intense training accelerates cellular aging through oxidative stress and inflammation, while disrupted sleep patterns (common among athletes) impair pineal function. Research into Epitalon focuses on its potential to counteract these effects by promoting cellular resilience, improving sleep quality through pineal support, and potentially extending the replicative capacity of stem cells and satellite cells crucial for muscle repair. Manufactured by Dragon Pharma in certified European laboratories, this 50 mg vial of lyophilized powder delivers exceptional purity and concentration, enabling researchers to conduct comprehensive studies on epigenetic regulation, telomere dynamics, and neuroendocrine health.

Key Benefits:

• Telomerase Activation Research: Studied for its potential to upregulate telomerase activity, which may help maintain telomere length—a key biomarker of cellular aging and replicative capacity.
• Pineal Gland Support & Melatonin Regulation: Helps normalize pineal gland function, potentially improving circadian rhythm synchronization and natural melatonin production for better sleep quality.
• Epigenetic & Gene Expression Modulation: Research suggests influence on gene expression patterns associated with aging, cellular repair, and stress resistance.
• Cellular Senescence Delay: May help delay the onset of cellular senescence (aging) in various tissues, supporting overall tissue health and function in aging models.
• High-Concentration Research Formula: 50 mg per vial provides substantial material for extended research cycles, combination studies, and dose-response experiments in longevity research.

Each 2 mL vial contains 50 mg of ultra-pure Epitalon tetrapeptide (Ala-Glu-Asp-Gly) as a sterile lyophilized powder, synthesized using advanced peptide chemistry under Dragon Pharma's exacting pharmaceutical-grade quality control standards.

Product Specifications

Usage Guidelines

Research Application Only: This information summarizes scientific literature for educational context. Dragon Pharma Epitalon 50 mg is a research chemical for laboratory investigation, not for human consumption.

In experimental settings, Epitalon is reconstituted with bacteriostatic water. Given its research focus on circadian rhythm and pineal function, administration is typically timed for the evening, approximately 1-2 hours before the subject's dark/sleep period in animal models. Subcutaneous administration is standard in preclinical research. Despite its short half-life, its epigenetic and gene-regulatory effects are cumulative and long-lasting, which is why research often uses relatively short daily cycles (20-30 days) with long breaks between. Studies may monitor telomere length (via qPCR), melatonin levels, sleep patterns, and biomarkers of oxidative stress and inflammation.

• Standard Anti-Aging Research Cycle (20-30 days): Daily evening administration protocol to study effects on telomerase activity, pineal function, and gene expression patterns in aging models.
• Intermittent Longevity Protocol: 20-30 day cycles repeated once or twice per year, based on research suggesting epigenetic changes persist long after administration ceases.

Post Cycle Therapy (PCT):

Epitalon does not affect the HPTA, so traditional PCT with SERMs like Nolvadex is not applicable. The research protocol itself includes the extended break (3-6 months) to allow observed epigenetic changes to manifest. During this period, studies might focus on maintaining cellular health with compounds like NAD+ precursors or GHK-Cu for continued collagen support and anti-inflammatory effects.

Synergistic Longevity & Performance Research:

Epitalon is often studied in combination with other compounds targeting different aging pathways. For comprehensive anti-aging research, it can be paired with Tesamorelin (for GH/IGF-1 optimization) or Ipamorelin. For mitochondrial support, combining with MOTS-c may be relevant. In athletic recovery models, it could be studied alongside BPC-157 for enhanced tissue repair at the cellular level. For cognitive longevity studies, Semax might be included in the research design.

Third-Party Lab Tested

2024-03-22

View Result

54.46 mg

Lab Analysis Note: The March 2024 third-party HPLC test shows 54.46 mg of Epitalon peptide per vial—exceeding the 50 mg label claim by 8.9%. This demonstrates exceptional batch potency and Dragon Pharma's commitment to delivering research-grade products that meet or exceed specifications. The purity is confirmed at ≥98% with the correct tetrapeptide sequence (Ala-Glu-Asp-Gly).

Storage Instructions

Proper storage is essential to preserve the integrity of this research peptide.

• Unreconstituted Powder: For maximum stability, store the sealed vial in a freezer at -20°C (-4°F) or colder. In this lyophilized state, Epitalon remains stable for at least 24 months. Protect from light and moisture, and avoid temperature fluctuations.
• After Reconstitution: Once reconstituted with bacteriostatic water, the solution must be refrigerated immediately at 2°C to 8°C (36°F to 46°F). The reconstituted solution is typically stable for research use for 3-4 weeks when refrigerated. For best results in epigenetic studies, use within 21 days. Do not freeze the liquid solution.
• Important Consideration: Given that research often uses Epitalon in short daily cycles, it's practical to reconstitute only enough for the 20-30 day study period to ensure maximum peptide integrity throughout the research protocol.